03:47 AM EDT, 03/26/2026 (MT Newswires) -- Ascentage Pharma Group ( AAPG ) reported a 2025 loss late Wednesday of 3.49 Chinese renminbi ($0.50) per diluted share, widening from a loss of 1.34 renminbi a year earlier.

Two analysts polled by FactSet expected 2.22 renminbi.

Revenue for the year ended Dec. 31 was 574.1 million renminbi, compared with 980.7 million renminbi a year earlier.

Four analysts polled by FactSet expected 525.3 million renminbi.

As of Dec. 31, 2025, cash and bank balances were $353.2 million, compared with $172.8 million a year earlier.